Bill Amendment: IL HB4900 | 2017-2018 | 100th General Assembly

NOTE: For additional amemendments please see the Bill Drafting List

---

Bill Title: GENERIC DRUG PRICING FAIRNESS

Status: 2019-01-08 - Session Sine Die [HB4900 Detail]

Download: Illinois-2017-HB4900-House_Amendment_001.html

---

Rep. Will Guzzardi

Filed: 4/16/2018

10000HB4900ham001 LRB100 20493 MJP 38544 a
AMENDMENT TO HOUSE BILL 4900
AMENDMENT NO. ______. Amend House Bill 4900 on page 1, line
5, by replacing "Illinois Generic Drug Pricing Fairness" with
"Pharmaceutical and Health Affordability: Restrictions on
Manufacturers' Amoral Behavior through Reasonable Oversight";
and
on page 2, line 7, after "Act.", by inserting ""Manufacturer"
does not include an entity operating as a wholesale drug
distributor as defined in Section 15 of the Wholesale Drug
Distribution Licensing Act."; and
on page 2, by replacing lines 10 through 14 with the following:
"(1) would result in the wholesale acquisition cost of
a 30-day supply of the essential off-patent or generic drug
exceeding $20 and would result in an increase in the
wholesale acquisition cost of the essential off-patent or
generic drug of:

10000HB4900ham001 - 2 - LRB100 20493 MJP 38544 a
(A) 30% or more within the preceding year;
(B) 50% or more within the preceding 3 years; or
(C) 75% or more within the preceding 5 years; or";
and
on page 3, line 9, after "drug", by inserting "that is
ultimately sold in Illinois"; and
on page 3, line 13, by replacing "additional costs" with "an
increase in the wholesale acquisition cost"; and
on page 3, line 15, after "drug", by inserting "or due to
market forces in those cases where there are multiple competing
generic drug products"; and
on page 4, lines 10 and 12, by replacing "price" each time it
appears with "wholesale acquisition cost".